Search Results
Evolving landscape of IO therapy in NSCLC management leveraging the multi disciplinary approach
Oncologist's Role in DigiPath
Drs. Levy, Johnson, Liu, & Lovly discuss #NSCLC at #TTLC23 - https://bit.ly/3E3FB74
Evolving standards of patient care in hepatocellular carcinoma
Call to Action: Critical Need to Address the Paucity of Novel Oncology Targets
Primary and Acquired Resistance to Cancer Immunotherapy
Novel Therapeutic Strategies to Individualize Patient Care in RCC: Expert-Led Clinical Consults
Lung Committee
Panel Discussion - CTI in 2030: What will the future look like and how will we get there?
Watch Prof. Solange Peters, MD, PhD, Mark M. Awad, MD, PhD, and Jonathan D. Spicer, MD, PhD, FRCS…
SIR-RFS Webinar 9/13/21: Interventional Immuno-oncology
Advances in Immunotherapy for Melanoma and Beyond
